220 related articles for article (PubMed ID: 28382787)
1. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
Arthritis Rheumatol; 2017 May; 69(5):898-910. PubMed ID: 28382787
[TBL] [Abstract][Full Text] [Related]
2. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778
[TBL] [Abstract][Full Text] [Related]
3. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; García-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J;
Ann Rheum Dis; 2017 May; 76(5):792-801. PubMed ID: 28385805
[TBL] [Abstract][Full Text] [Related]
4. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Saad Magalhaes C; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
Ann Rheum Dis; 2017 May; 76(5):782-791. PubMed ID: 28385804
[TBL] [Abstract][Full Text] [Related]
5. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.
Rider LG; Ruperto N; Pistorio A; Erman B; Bayat N; Lachenbruch PA; Rockette H; Feldman BM; Huber AM; Hansen P; Oddis CV; Lundberg IE; Amato AA; Chinoy H; Cooper RG; Chung L; Danko K; Fiorentino D; García-De la Torre I; Reed AM; Wook Song Y; Cimaz R; Cuttica RJ; Pilkington CA; Martini A; van der Net J; Maillard S; Miller FW; Vencovsky J; Aggarwal R;
Rheumatology (Oxford); 2017 Nov; 56(11):1884-1893. PubMed ID: 28977549
[TBL] [Abstract][Full Text] [Related]
6. Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles.
Saygin D; Kim H; Douglas C; Erman B; Wilkerson J; McGrath JA; Oddis CV; Lundberg IE; Amato AA; García-De La Torre I; Chinoy H; Fiorentino D; Chung L; Song YW; Miller FW; Ruperto N; Vencovsky J; Aggarwal R; Rider LG;
Rheumatology (Oxford); 2023 Nov; 62(11):3672-3679. PubMed ID: 36929923
[TBL] [Abstract][Full Text] [Related]
7. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis.
Aggarwal R; Marder G; Koontz DC; Nandkumar P; Qi Z; Oddis CV
Ann Rheum Dis; 2018 May; 77(5):720-727. PubMed ID: 29237618
[TBL] [Abstract][Full Text] [Related]
9. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study.
Ruperto N; Ravelli A; Pistorio A; Ferriani V; Calvo I; Ganser G; Brunner J; Dannecker G; Silva CA; Stanevicha V; Cate RT; van Suijlekom-Smit LW; Voygioyka O; Fischbach M; Foeldvari I; Hilario O; Modesto C; Saurenmann RK; Sauvain MJ; Scheibel I; Sommelet D; Tambic-Bukovac L; Barcellona R; Brik R; Ehl S; Jovanovic M; Rovensky J; Bagnasco F; Lovell DJ; Martini A; ;
Arthritis Rheum; 2008 Jan; 59(1):4-13. PubMed ID: 18163404
[TBL] [Abstract][Full Text] [Related]
10. Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.
Paik JJ; Casciola-Rosen L; Shin JY; Albayda J; Tiniakou E; Leung DG; Gutierrez-Alamillo L; Perin J; Florea L; Antonescu C; Leung SG; Purwin G; Koenig A; Christopher-Stine L
Arthritis Rheumatol; 2021 May; 73(5):858-865. PubMed ID: 33258553
[TBL] [Abstract][Full Text] [Related]
11. The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.
Ruperto N; Pistorio A; Ravelli A; Rider LG; Pilkington C; Oliveira S; Wulffraat N; Espada G; Garay S; Cuttica R; Hofer M; Quartier P; Melo-Gomes J; Reed AM; Wierzbowska M; Feldman BM; Harjacek M; Huppertz HI; Nielsen S; Flato B; Lahdenne P; Michels H; Murray KJ; Punaro L; Rennebohm R; Russo R; Balogh Z; Rooney M; Pachman LM; Wallace C; Hashkes P; Lovell DJ; Giannini EH; Gare BA; Martini A; ;
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1533-41. PubMed ID: 20583105
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Oddis CV; Reed AM; Aggarwal R; Rider LG; Ascherman DP; Levesque MC; Barohn RJ; Feldman BM; Harris-Love MO; Koontz DC; Fertig N; Kelley SS; Pryber SL; Miller FW; Rockette HE;
Arthritis Rheum; 2013 Feb; 65(2):314-24. PubMed ID: 23124935
[TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.
Aggarwal R; Bandos A; Reed AM; Ascherman DP; Barohn RJ; Feldman BM; Miller FW; Rider LG; Harris-Love MO; Levesque MC; ; Oddis CV
Arthritis Rheumatol; 2014 Mar; 66(3):740-9. PubMed ID: 24574235
[TBL] [Abstract][Full Text] [Related]
14. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Torre IG; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
Ann Rheum Dis; 2017 Dec; 76(12):1955-1964. PubMed ID: 29079590
[TBL] [Abstract][Full Text] [Related]
15. Role of bone scan in the assessment of polymyositis/dermatomyositis.
An YS; Suh CH; Jung JY; Kim HA
Clin Rheumatol; 2015 Apr; 34(4):699-706. PubMed ID: 25501462
[TBL] [Abstract][Full Text] [Related]
16. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
American College of Rheumatology Committee to Reevaluate Improvement Criteria
Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
[TBL] [Abstract][Full Text] [Related]
17. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ravelli A; Minoia F; Davì S; Horne A; Bovis F; Pistorio A; Aricò M; Avcin T; Behrens EM; De Benedetti F; Filipovic L; Grom AA; Henter JI; Ilowite NT; Jordan MB; Khubchandani R; Kitoh T; Lehmberg K; Lovell DJ; Miettunen P; Nichols KE; Ozen S; Pachlopnik Schmid J; Ramanan AV; Russo R; Schneider R; Sterba G; Uziel Y; Wallace C; Wouters C; Wulffraat N; Demirkaya E; Brunner HI; Martini A; Ruperto N; Cron RQ; ; ; ;
Ann Rheum Dis; 2016 Mar; 75(3):481-9. PubMed ID: 26865703
[TBL] [Abstract][Full Text] [Related]
18. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M; ;
Arthritis Rheum; 2011 Mar; 63(3):573-86. PubMed ID: 21294106
[TBL] [Abstract][Full Text] [Related]
19. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
[TBL] [Abstract][Full Text] [Related]
20. Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.
Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson PJ; Lundberg IE; Korotkova M
Arthritis Res Ther; 2018 May; 20(1):83. PubMed ID: 29720222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
